Target intelligence / Profile preview

Spermatogenesis associated 13 (SPATA13)

Target
SPATA13
Molecular classification
Guanine nucleotide exchange factor (GEF), Protein binding, Pleckstrin homology domain containing family (PLEKH), Rho guanine nucleotide exchange factor family (ARHGEF)
01

Overview

Spermatogenesis associated 13 (SPATA13) is a protein-coding gene encoding a guanine nucleotide exchange factor (GEF) that activates small GTPases such as Rac1, RhoA, and Cdc42, orchestrating actin cytoskeletal rearrangements essential for cell migration and adhesion[1][2][4][5]. SPATA13 interacts with proteins like the tumor suppressor APC and modulates membrane dynamics, lamellipodia, and filopodia formation[1]. Its activity is regulated by post-translational modifications—phosphorylation at serine 106 notably alters its ability to activate Rac1 and affect cell movement[1]. SPATA13 is implicated in human disease, notably primary angle-closure glaucoma, cancer progression, and rare neuropsychiatric disorders[1][2][3][5]. Its expression is enriched in brain regions such as the central amygdala, where loss of SPATA13 affects social behaviors and voluntary activity in animal models[3].

Other names
Asef2ARHGEF29SPT13_HUMAN (UniProt name)
02

Mechanism of action

Not applicable/none reported. As of now, no drugs are noted to target SPATA13 directly, so mechanism by which drugs modulate its activity is undefined

03

Biological functions

Cell migrationActin cytoskeletal dynamicsRegulation of cell adhesionPlasma membrane-bounded cell projection assemblyRegulation of directional migration and adhesion turnoverModulation of social behavior, especially social hierarchyDendritic spine formation (glutamatergic)
04

Disease associations

Cancer (colorectal tumor cells; intestinal adenoma formation and tumor progression)Eye diseases (primary angle-closure glaucoma, optic atrophy 3)Intellectual disability (rare variants)Depression and alcohol dependence (GWAS hit)Potential role in tumor angiogenesis
05

Safety considerations

None directly reported or known as therapeutic challenges for SPATA13Knockout animal models do not display gross phenotypic or behavioral concerns aside from effects on social dominance and activity

Beyond the preview

Go deeper on Spermatogenesis associated 13 (SPATA13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spermatogenesis associated 13 (SPATA13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call